Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.

Show other versions (1)

<p class="MsoNormal" style="margin: 1pt 7.0865pt; text-align: justify;"><strong><span style="font-weight: bold; font-family: Tahoma;">Background</span></strong><span style="font-family: Tahoma;"><strong>:</strong>...

Full description

Bibliographic Details
Main Authors:	Leslie Pérez Ruiz, Ana María Ramos Cedeño, José Cabrera Gómez, Nancy Echazábal Santana, Hailen Bobillo López
Format:	Article
Language:	Spanish
Published:	Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2007-12-01
Series:	Medisur
Subjects:	interferón-alfa 2b ensayos clínicos esclerosis múltiple
Online Access:	http://www.medisur.sld.cu/index.php/medisur/article/view/288

Similar Items

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
by: Leslie Pérez Ruiz, et al.
Published: (2007-12-01)

Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis
by: Rosa F. Lara Rodríguez, et al.
Published: (2007-05-01)

Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis
by: Rosa F. Lara Rodríguez, et al.
Published: (2007-05-01)

Systemic sclerosis induced by interferon-alfa treatment of melanoma.
by: Joana Leite Silva, et al.
Published: (2017-07-01)

Using Recombinant Interferon Alpha-2b in Pediatric Practice
by: Yu.V. Marushko, et al.
Published: (2016-03-01)

Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado
by: Eduardo Lorens Braga, et al.
Published: (2006-12-01)

Interferon-induced depression in patients with hepatitis C: an epidemiologic study
by: Lucas Pereira Jorge de Medeiros, et al.
Published: (2014-02-01)

Literature systematic review on the ophthalmological side effects of interferons
by: Yara Dadalti Fragoso, et al.
Published: (2011-08-01)

Desarrollo de panuveítis por tuberculosis en paciente con esclerosis múltiple tratado con interferón beta
by: Lucía Echevarría Lucas, et al.
Published: (2016-09-01)

Tratamento de hemangioma gigante com interferon alfa: relato de dois casos Treatment of giant hemangioma with interferon-alpha: report of two cases
by: Ana Julia Balau, et al.
Published: (2007-12-01)

A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis
by: E.J. Ramos González, et al.
Published: (2021-05-01)

Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon
by: Patrícia Alessandra Dastoli, et al.
Published: (2011-02-01)

Grupos sanguíneos ABO, RhD y esclerosis múltiple ABO and RhD blood groups in multiple sclerosis
by: Leslie Pérez-Ruiz, et al.
Published: (2011-06-01)

Preventive vaccines for COVID-19. An expectant reality
by: Ana María Ramos Cedeño, et al.
Published: (2020-11-01)

Ocular changes due to systemic alpha-interferon therapy for hepatitis C Alterações oculares por uso sistêmico de alfa-interferon em pacientes com hepatite C
by: Liang Shih Jung, et al.
Published: (2004-12-01)

Tuberous sclerosis. Case presentation.
by: Graciela Caridad Cabrera Acea, et al.
Published: (2009-03-01)

Tuberous sclerosis. Case presentation.
by: Graciela Caridad Cabrera Acea, et al.
Published: (2009-03-01)

Ensayos clínicos cubanos publicados en revistas de impacto internacional: estudio bibliométrico del período 1991-2001
by: Juan Antonio Araujo Ruiz, et al.
Published: (2002-09-01)

Poly-ε-caprolactone microspheres containing interferon alpha as alternative formulations for the treatment of chronic hepatitis C
by: Cristiane da Silva Melo, et al.
Published: (2012-03-01)

Análise de interferon humano recombinante presente em formulações farmacêuticas | Recombinant human interferon analysis in pharmaceutical formulations
by: Sinéa Mendes de Andrade, et al.
Published: (2017-08-01)

Epidermodisplasia verruciforme: tratamento combinado com acitretina e interferon alfa-2a Epidermodysplasia verruciformis: combined treatment with acitretin and interferon alpha-2a
by: Cristiana Silveira Silva, et al.
Published: (2006-12-01)

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
by: Marisa Boff Costa, et al.
Published: (2018-01-01)

Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
by: Erélido Hernández Valero, et al.
Published: (2007-08-01)

Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
by: Erélido Hernández Valero, et al.
Published: (2007-08-01)

Tratamento de pacientes com hepatite crônica pelo vírus C com interferon-alfa e ribavirina: a experiência da Secretaria de Saúde do Rio Grande do Sul Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil
by: Alexandro Vaesken Alves, et al.
Published: (2003-12-01)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

Interferon-associated retinopathy in a patient with metastatic melanoma
by: Lara Borrego-Sanz, et al.
Published: (2014-10-01)

Problemas en el reclutamiento de pacientes con cáncer de pulmón y metástasis cerebral en un ensayo clínico.
by: Nadia Aguilera Calvo, et al.
Published: (2016-03-01)

Problemas en el reclutamiento de pacientes con cáncer de pulmón y metástasis cerebral en un ensayo clínico
by: Nadia Aguilera Calvo, et al.

Immunonutrition in clinical practice: what is the current evidence?
by: S. D. Heys, et al.

DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
by: Izabella Liguori Corsino VABO, et al.

An Oral Multiple Papillomatosis Case Treated with Interferon Alfa 2a
by: Semih TATLICAN, et al.
Published: (2000-09-01)

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon – Ribavirin in daily practice
by: Ezequiel Ridruejo, MD., et al.
Published: (2010-01-01)

O poder e as injustiças nas pesquisas em seres humanos
by: William Saad Hossne

Investigación Clínica & Ensayos Clínicos Desafíos y Perspectivas
by: Thelvia I Ramos
Published: (2017-11-01)

O poder e as injustiças nas pesquisas em seres humanos
by: William Saad Hossne
Published: (2003-02-01)

Análise de interferon humano recombinante presente em formulações farmacêuticas
by: Sinéa Mendes de Andrade, et al.
Published: (2017-08-01)

Análise de interferon humano recombinante presente em formulações farmacêuticas
by: Sinéa Mendes de Andrade, et al.
Published: (2017-08-01)

Análise de interferon humano recombinante presente em formulações farmacêuticas
by: Sinéa Mendes de Andrade, et al.
Published: (2017-08-01)

Análise de interferon humano recombinante presente em formulações farmacêuticas
by: Sinéa Mendes de Andrade, et al.
Published: (2017-08-01)